Inorganic nanowires
AM Belcher, C Mao, DJ Solis - US Patent 7,923,109, 2011 - Google Patents
An inorganic nanowire having an organic scaffold substantially removed from the inorganic
nanowire, the inorganic nanowire consisting essentially of fused inorganic nanoparticles …
nanowire, the inorganic nanowire consisting essentially of fused inorganic nanoparticles …
Glycotargeting therapeutics
JA Hubbell, DS Wilson - US Patent 10,046,056, 2018 - Google Patents
2018-06-25 Assigned to ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL)
reassignment ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) …
reassignment ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) …
Biofabrication of transistors including field effect transistors
E Hu - US Patent App. 11/130,399, 2006 - Google Patents
Use of peptides and other biological agents for fabrication of transistors, field effect
transistors, and components thereof. An intermediate component for use in fabrication of a …
transistors, and components thereof. An intermediate component for use in fabrication of a …
Alternatively targeted adenovirus
TJ Wickham, I Kovesdi, PW Roelvink… - US Patent …, 2002 - Google Patents
The various physiological responses of a host animal to the presence of a virus depend on
the different ways Such viruses interact with the host animal, each of which is first mediated …
the different ways Such viruses interact with the host animal, each of which is first mediated …
Glycotargeting therapeutics
JA Hubbell, DS Wilson - US Patent 10,946,079, 2021 - Google Patents
US10946079B2 - Glycotargeting therapeutics - Google Patents US10946079B2 -
Glycotargeting therapeutics - Google Patents Glycotargeting therapeutics Download PDF …
Glycotargeting therapeutics - Google Patents Glycotargeting therapeutics Download PDF …
Erythrocyte-binding therapeutics
JA Hubbell, S Kontos, KY Dane - US Patent 10,800,838, 2020 - Google Patents
(63) Related US Application Data Continuation of application No. 14/460,768, filed on Aug.
15, 2014, now Pat. No. 9,850,296, which is a continuation of application No …
15, 2014, now Pat. No. 9,850,296, which is a continuation of application No …
Erythrocyte-binding therapeutics
JA Hubbell, S Kontos, KY Dane - US Patent 9,850,296, 2017 - Google Patents
(63) Continuation of application No. PCT/IB2013/000684, filed on Feb. 15, 2013, and a
continuation-in-part of application No. 13/397, 202, filed on Feb. 15, 2012, now Pat. No. 9 …
continuation-in-part of application No. 13/397, 202, filed on Feb. 15, 2012, now Pat. No. 9 …
Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob
DT Curiel, VN Krasnykh, I Dmitriev - US Patent 7,297,542, 2007 - Google Patents
The present invention provides means to modify the tropism of recombinant adenoviral
vectors using genetic methods to alter the adenoviral fiber cell-binding protein. The present …
vectors using genetic methods to alter the adenoviral fiber cell-binding protein. The present …
Ccr7 ligand delivery and co-delivery in immunotherapy
4,687,481 A 8/1987 Nuwayser 5,142,047 A 8, 1992 Summerton et al. 5,185,444 A 2, 1993
Summerton et al. 5,227,293 A 7/1993 Stengelin et al. 5,279,544 A 1/1994 Gross et al. 5.330 …
Summerton et al. 5,227,293 A 7/1993 Stengelin et al. 5,279,544 A 1/1994 Gross et al. 5.330 …
Non-natural ribonuclease conjugates as cytotoxic agents
LE Strong, PA Leland, T Burke - US Patent 8,470,315, 2013 - Google Patents
The present invention is directed toward the delivery of a toxic protein to pathogenic cells,
particularly cancer cells. In preferred embodiments, the toxic protein is a ribonuclease that …
particularly cancer cells. In preferred embodiments, the toxic protein is a ribonuclease that …